Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Credit rating agency...

    Credit rating agency downgrades Fortis

    Written by Ruby Khatun Khatun Published On 2018-04-12T11:18:33+05:30  |  Updated On 12 April 2018 11:18 AM IST
    Credit rating agency downgrades Fortis

    New Delhi: Rating agency ICRA has downgraded Fortis Healthcare and its subsidiaries Escorts Heart Institute and Research Centre, Fortis Hospitals and Hiranandani Healthcare, citing stretched liquidity position of the company which led to delay in servicing of a loan.


    The long-term rating of Fortis Healthcare Ltd (FHL) for Rs 250 crore non-convertible debenture programme, Rs 105 crore fund-based limits, and Rs 195 crore term loans has been revised to 'C' from BBB, ICRA said in a statement.


    'C' rating reflects the very high risk of default regarding timely servicing of financial obligations as against moderate degree of safety regarding timely servicing of financial obligations for 'BBB', as per ICRA.


    Further, the short-term rating for Rs 600 crore commercial paper programme and Rs 20 crore non-fund-based facilities have been revised from A3 (instruments carrying higher credit risk) to A4 (instruments carrying very high credit risk and are susceptible to default), ICRA said.


    The ratings have been removed from the watch with negative implications, it added.


    Commenting on the rationale of the rating downgrade on FHL, ICRA said,"The rating action takes into account delay in servicing of a loan not rated by ICRA. The delay was on account of stretched liquidity position of the company along with its inability to roll over or refinance the loan".


    FHL's ratings continue to be constrained by concerns pertaining to the recoverability of advances extended to related parties, potential impact of various ongoing investigations/ litigations, deterioration in operational performance and large payments being made to Religare Health Trust (RHT), it added.


    While downgrading several debt instruments of Escorts Heart Institute and Research Centre, ICRA said the rating action followed revision of ratings on rated instruments of FHL due to strong operational, financial, and managerial linkage between the two entities.


    Similarly, ICRA said it has downgraded ratings of debt instruments of Fortis Hospitals Ltd (FHsL) following the revision in ratings assigned to FHL.


    On Hiranandani Healthcare also, ICRA cited similar reasons for the changed ratings of FHL for downgrade on its credit ratings.

    Credit rating agencydowngradesEscorts Heart Institute and Research CentreFHLFortisFortis HealthcareFortis Healthcare LtdFortis HospitalsHiranandani HealthcareICRAIndian credit rating agencyReligare Health Trust
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok